Rationalistic approach in COVID-19 prevention through intervention of Unani medicine prevalent in epidemic - A review.

Fatima Khan, Abdul Nasir Ansari, Mohd Nayab
Author Information
  1. Fatima Khan: Department of Ilaj Bit Tadbeer, National Institute of Unani Medicine, Bangalore, India.
  2. Abdul Nasir Ansari: Department of Ilaj Bit Tadbeer, National Institute of Unani Medicine, Bangalore, India.
  3. Mohd Nayab: Department of Ilaj Bit Tadbeer, National Institute of Unani Medicine, Bangalore, India.

Abstract

INTRODUCTION: A novel coronavirus virus (2019-nCoV) emerged in China in December 2019 and achieved a high-risk category by the World Health Organization (WHO). The initial symptoms included fever, cough, dyspnea, and sore throat. The present review aims to evaluate the available evidence for the safety and efficacy of herbal drugs and formulations in the prevention of (epidemic diseases) having resemblance to SARS-CoV-2.
METHODS: Sources of data for this paper are classical textbooks, pharmacopeia of India, , and published articles in various reputed peer-reviewed journals. Collected information was then critically analyzed.
RESULTS: Despite great efforts, no specific treatment has been discovered for coronavirus yet. The best choices, therefore, are prevention and management. The system of medicine offers health protection during epidemics. Three important interventions practised during an outbreak are (i) purification of the environment by using certain herbal drugs as fumigants which include vinegar (acetic acid) alone or combined with Regel; (ii) promotion of health and immune modulation by using the pharmacopoeial preparations and
CONCLUSION: Several single drugs, as well as compound formulations, have been recommended in medicine for the prevention and treatment of infectious diseases. The pharmacopoeial preparation has been used for respiratory catarrhal inflammations and influenza by of the medieval period. Scientific research on these drugs reveals the presence of many pharmacologically active substances possessing significant antiviral, antipyretic, anti-tussive, and immune-modulatory properties, which can give new insight into infection and epidemic management.

Keywords

References

  1. Foods. 2020 Apr 22;9(4): [PMID: 32331259]
  2. J Gen Intern Med. 2020 May;35(5):1545-1549 [PMID: 32133578]
  3. N Engl J Med. 2020 Feb 20;382(8):727-733 [PMID: 31978945]
  4. Cureus. 2020 Mar 21;12(3):e7352 [PMID: 32328364]
  5. Lancet. 2020 Mar 28;395(10229):1015-1018 [PMID: 32197103]
  6. Drugs Ther Perspect. 2020 Mar 7;:1-3 [PMID: 32218651]
  7. J Chin Med Assoc. 2020 Mar;83(3):217-220 [PMID: 32134861]
  8. J AOAC Int. 2019 Jul 1;102(4):977-978 [PMID: 30558694]
  9. J Med Virol. 2020 Apr;92(4):418-423 [PMID: 31967327]
  10. Infect Dis Poverty. 2020 Mar 17;9(1):29 [PMID: 32183901]
  11. Front Med. 2020 Apr;14(2):229-231 [PMID: 32212058]
  12. J Nat Prod. 2003 Jul;66(7):1022-37 [PMID: 12880330]
  13. Lancet. 2020 Feb 22;395(10224):542-545 [PMID: 32061313]
  14. Phytother Res. 2018 May;32(5):811-822 [PMID: 29356205]
  15. J Travel Med. 2020 Mar 13;27(2): [PMID: 32052841]
  16. Sci Total Environ. 2020 Aug 1;728:138859 [PMID: 32334163]
  17. JAMA. 2020 Apr 14;323(14):1339-1340 [PMID: 32108857]
  18. Infez Med. 2020 Mar 1;28(1):3-5 [PMID: 32009128]
  19. Mil Med Res. 2020 Mar 13;7(1):11 [PMID: 32169119]
  20. Cureus. 2020 Apr 6;12(4):e7560 [PMID: 32269893]
  21. Sci Total Environ. 2020 Jul 10;725:138277 [PMID: 32278175]
  22. Indian J Pediatr. 2020 Apr;87(4):281-286 [PMID: 32166607]
  23. Indian J Hist Sci. 1981 Nov;16(2):139-44 [PMID: 11611786]
  24. Pharmacogn Rev. 2014 Jul;8(16):73-80 [PMID: 25125878]
  25. J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S152-S156 [PMID: 32515399]
  26. Nat Med. 2020 Apr;26(4):450-452 [PMID: 32284615]
  27. Int J Epidemiol. 2020 Jun 1;49(3):717-726 [PMID: 32086938]
  28. Lancet Psychiatry. 2020 Apr;7(4):300-302 [PMID: 32085840]
  29. N Engl J Med. 2020 Mar 26;382(13):1268-1269 [PMID: 32109011]
  30. Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1059-65 [PMID: 15306390]
  31. Lancet Infect Dis. 2020 Apr;20(4):398-400 [PMID: 32113510]
  32. Clin Oral Investig. 2020 Apr;24(4):1619-1621 [PMID: 32078048]
  33. Trop Med Int Health. 2020 Mar;25(3):278-280 [PMID: 32052514]

Word Cloud

Created with Highcharts 10.0.0drugspreventionepidemicmedicinecoronavirus2019-nCoVreviewherbalformulationsdiseasesSARS-CoV-2treatmentmanagementhealthusingpharmacopoeialINTRODUCTION:novelvirusemergedChinaDecember2019achievedhigh-riskcategoryWorldHealthOrganizationWHOinitialsymptomsincludedfevercoughdyspneasorethroatpresentaimsevaluateavailableevidencesafetyefficacyresemblanceMETHODS:SourcesdatapaperclassicaltextbookspharmacopeiaIndiapublishedarticlesvariousreputedpeer-reviewedjournalsCollectedinformationcriticallyanalyzedRESULTS:DespitegreateffortsspecificdiscoveredyetbestchoicesthereforesystemoffersprotectionepidemicsThreeimportantinterventionspractisedoutbreakpurificationenvironmentcertainfumigantsincludevinegaraceticacidalonecombinedRegeliipromotionimmunemodulationpreparationsCONCLUSION:SeveralsinglewellcompoundrecommendedinfectiouspreparationusedrespiratorycatarrhalinflammationsinfluenzamedievalperiodScientificresearchrevealspresencemanypharmacologicallyactivesubstancespossessingsignificantantiviralantipyreticanti-tussiveimmune-modulatorypropertiescangivenewinsightinfectionRationalisticapproachCOVID-19interventionUnaniprevalent-CoronavirusEpidemicTiryaqWabaiAmraz

Similar Articles

Cited By